Ernexa Therapeutics Inc. Common Stock
Symbol: ERNA (NASDAQ)
1.17
▲ (1.74%) 0.020
Company Description:
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
Key Stats
- Today's Open: $1.14
- Today's High: $1.21
- Today's Low: $1.116
- Today's Volume: 26.82K
- Yesterday Close: $1.15
- Yesterday High: $1.2007
- Yesterday Low: $1.105
- Yesterday Volume: 52.18K
- Last Min Volume: 1
- Last Min High: $1.17
- Last Min Low: $1.17
- Last Min VWAP: $1.17
Company Profile
- Name: Ernexa Therapeutics Inc. Common Stock
- Website: https://www.ernexatx.com
- Listed Date: 2021-03-26
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0000748592
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.28M
- Round Lot: 100
- Outstanding Shares: 7.67M
- Asset Type: CS
RECENT FILINGS FOR ERNA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-18 | SCHEDULE 13G/A | View |
| 2025-08-13 | 10-Q | View |
| 2025-07-07 | 4 | View |
| 2025-07-07 | 8-K | View |
| 2025-06-18 | EFFECT | View |
| 2025-06-18 | 424B3 | View |
| 2025-06-16 | CORRESP | View |
| 2025-06-16 | UPLOAD | View |
| 2025-06-12 | 8-K | View |
| 2025-06-11 | SCHEDULE 13D/A | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | S-8 | View |
| 2025-06-11 | S-3 | View |
| 2025-06-09 | 8-K | View |
| 2025-06-02 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-07 | 10-Q | View |
Latest News on ERNA